 |
|
|
|
|
|
|
|
|
|
| |
 |
General Biosafety Guidance
|
|
|
| |
|
Introduction to Risk Assessment
|
|
|
| |
|
Wild Type Influenza Viruses
|
|
|
| |
|
Wild Type SARS-CoV
|
|
|
| |
|
Examples of Risk Assessment Templates
|
|
|
| |
|
Examples Risk Assessments - Presentations
|
|
|
| |
|
Recombinant Influenza Virus and SARS-CoV References
|
|
|
| |
|
Occupational Medical Services for Biomedical Research |
|
| |
|
|
|
|
General Biosafety Guidance |
|
|
| |
|
NIH Guidelines for Research Involving Recombinant DNA Molecules |
|
|
| |
|
Biosafety in Microbiological and Biomedical Laboratories 5th edition |
|
|
| |
|
USDA ARS CSREES ERS NASS Manual- Chapter 9.4.4 Biosafety Level 3 Agriculture (BSL-3Ag) |
|
|
| |
|
World Health Organization Laboratory Biosafety Manual 3rd edition |
|
|
| |
|
Health Canada Material Safety Data Sheets |
|
|
| |
|
American Biological Safety Association |
|
|
| |
|
American Industrial Hygiene Association |
|
Top of Page |
|
|
|
|
Introduction to Risk Assessment |
|
|
| |
|
Slides from Dr. E. Barkley's presentation |
|
|
| |
|
NIH Guidelines template |
|
Top of Page |
|
|
|
|
Information and Biosafety Guidance for Wild Type Influenza Viruses |
|
|
| |
|
CDC Update on Avian Influenza A (H5N1) (Aug. 12, 2004) |
|
|
| |
|
Avian Influenza: USDA Permitting Requirements under 9 CFR 122 (L. A. Thomas presentation) |
|
|
| |
|
USDA/CDC Select Agent Program: Data Necessary to Consider Select Agent Exclusion Requests Attentuated Strains of Highly Pathogenic Avian Influenza Viruses |
|
|
| |
|
WHO Production of pilot lots of inactivated influenza vaccines from reassortants derived from avian influenza viruses |
|
|
| |
|
Health Canada Biosafety Advisory Highly Pathogenic Avian Influenza |
|
|
| |
|
United Kingdom Health and Safety Executive Advice on Assessing the Risks of Working with Highly Pathogenic Avian Influenza Virus |
|
|
| |
|
Avian Influenza Virus Program at the Virginia-Maryland Regional College of Veterinary Medicine |
|
|
| |
|
Interim CDC-NIH Recommendation for Raising the Biosafety Level for Laboratory Work Involving Noncontemporary Human Influenza (H2N2) Viruses (May 2005) |
|
|
| |
|
Revisions to the influenza summary statement for the 5th edition of the BMBL (Dr. J Katz presentation at 6/2005 RAC meeting) |
|
|
| |
|
Harmonization of the NIH Guidelines with other federal Guidances: Biological containment for work with noncontemporary strains of influenza (Dr. K. Harris presentation at 6/2005 RAC meeting) |
|
Top of Page |
|
|
|
|
Biosafety Guidance for Wild Type SARS-CoV |
|
|
| |
|
WHO biosafety Guidelines for handling of SARS specimens |
|
|
| |
|
WHO post-outbreak biosafety guidelines for handling of SARS-CoV specimens and cultures |
|
|
| |
|
WHO Alert, verification, and public health management of SARS in the post-outbreak period |
|
|
| |
|
United Kingdom Health and Safety Advisory Severe acute respiratory syndrome (SARS) |
|
Top of Page |
|
|
|
|
Examples of Risk Assessment Templates for Pathogenic Virus Research |
|
|
| |
|
Influenza viruses |
|
|
| |
|
Recombinant influenza virus containment |
|
|
| |
|
Coronaviruses |
|
Top of Page |
|
|
|
|
Examples of Risk Assessments |
|
|
| |
|
Slides from Dr. Y. Kawaoka's presentation: H5N1 and 1918 influenza viruses |
|
|
| |
|
Slides from Dr. A. Garcia-Sastre's presentation: 1918 influenza virus |
|
|
| |
|
Slide from Dr. R. Webster's presentation: Containment for HPAI research |
|
|
| |
|
Slides from Dr. R. Baric's presentation: SARS-CoV |
|
Top of Page |
|
|
|
|
Recombinant Influenza Virus and SARS-CoV References |
|
|
| |
|
Tumpey, T., et al., (2004) Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus, PNAS 101:3166-3171. |
|
|
| |
|
Webby, R., and R. Webster, (2003) Are we ready for pandemic influenza? Science 302:1519-1522. |
|
|
| |
|
Enserink, M., (2004) Tiptoeing around Pandora's box, Science 305: 594-595. |
|
|
| |
|
Holmes, K., and L. Enjuanes, (2003) The SARS coronavirus: A postgenomic era Science 300: 1377-1378. |
|
|
| |
|
Yount, B. et al., Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus PNAS 100:12995-13000. |
|
Top of Page |
